+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine



Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine



American Journal of Tropical Medicine and Hygiene 26(3): 562-563



Glucose-6-phosphate dehydrogenase-normal adult volunteers infected with mosquito-bone Chesson strain vivax malaria were treated with chloroquine and primaquine during the initial attack. Administration of 60 mg (base) of primaquine daily for 7 days was as effective in preventing relapse as is the regimen customarily used for the radical cure of infections produced by this strain, namely, 30 mg daily for 14 days. However, it is stressed that because of the risk of primaquine-induced hemolysis in individuals having genetically-transmitted erythrocyte abnormalities this high dosage should not be used routinely.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 006250091

Download citation: RISBibTeXText

PMID: 326072


Related references

A combination of amodiaquin and primaquine (camoprim) in the prevention and cure of sporozoite-induced Chesson strain vivax malaria. American Journal of Tropical Medicine and Hygiene 9: 149-154, 1960

Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. American Journal of Tropical Medicine and Hygiene 2(6): 949-957, 1953

Primaquine and quinocide as curative agents against sporozoite-induced Chesson strain vivax malaria. Bulletin of the World Health Organization 27: 290-293, 1962

The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. Journal of Laboratory and Clinical Medicine 44(3): 429-438, 1954

A combination of Amodiaquin and primaquine in the prevention and cure of sporozoite-induced Chesson strain yivax malaria. Amer Jour Trop Med And Hyg 9(2): 149-154, 1960

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. American Journal of Tropical Medicine and Hygiene 82(4): 542-547, 2010

Compliance with 14-day primaquine therapy for radical cure of vivax malaria - a randomized placebo-controlled trial comparing unsupervised with supervised treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 98(3): 168-173, 2004

Primaquine; a new drug for the radical cure of relapsing vivax malaria. Journal of the Medical Association of Georgia 41(4): 126, 1952

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. Plos Neglected Tropical Diseases 12(4): E0006440, 2018

Studies in human malaria. XXVII. Observations on the use of pentaquine in the prevention and treatment of Chesson strain vivax malaria. Journal. National Malaria Society 9(3): 222-233, 1950

Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. American Journal of Tropical Medicine and Hygiene 62(3): 393-395, 2000

Radical Cure of Vivax Malaria : 5 or 14 Days. Medical Journal Armed Forces India 58(3): 285-286, 2002

Radical cure of vivax malaria: five or 14 days?. Journal of the Association of Physicians of India 50: 1200, 2002

Therapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India. Korean Journal of Parasitology 54(6): 733-742, 2016

A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India. Malaria Journal 17(1): 321, 2018